Adam D Cohen MD

PubMed

• BCMA-directed CAR T-cell therapy in patients with multiple myeloma and CNS involvement.
  Mahmoud R Gaballa, Omar Castaneda Puglianini, Adam Cohen, Dan Vogl, Alfred Chung
  Blood Advances. 2025-03-11
• 2 citations
  International myeloma working group immunotherapy committee recommendation on sequencing immunotherapy for treatment of multiple myeloma.
  Luciano J Costa, Rahul Banerjee, Hira Mian, Katja Weisel, Susan Bal
  Leukemia. 2025-03-01
• Safety and Efficacy of Teclistamab in Patients With Relapsed or Refractory AL Amyloidosis.
  Margaret Stalker, Alfred Garfall, Adam Cohen, Dan T Vogl, Mia Djulbegovic
  European Journal of Haematology. 2025-03-01

Abstracts/Posters

• Combination Anti-Bcma and Anti-CD19 CAR T Cells As Consolidation of Response to Prior Therapy in Multiple Myeloma
  Adam D. Cohen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• First-in-Human Assessment of Feasibility and Safety of Multiplexed Genetic Engineering of Autologous T Cells Expressing NY-ESO -1 TCR and CRISPR/Cas9 Gene Edited to El...
  Adam D. Cohen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Identification and Validation of Predictive Biomarkers to CD19- and BCMA-Specific CAR T-Cell Responses in CAR T-Cell Precursors
  Adam D. Cohen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Results of the Phase 3 VITAL Study of NEOD001 (Birtamimab) Plus Standard of Care in Patients with Light Chain (AL) Amyloidosis Suggest Survival Benefit for Mayo Stage ...
  Adam D. Cohen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Phase 2 Study of the Response and Safety of P-Bcma-101 CAR-T Cells in Patients with Relapsed/Refractory (r/r) Multiple Myeloma (MM) (PRIME)Clinically Relevant Abstract
  Adam D. Cohen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Join now to see all

Lectures

• Immunotherapy in Myeloma 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Clinical Predictors of T Cell Fitness for CAR T Cell Manufacturing and Efficacy in Multiple Myeloma 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• PD-1 Inhibitor Combinations As Salvage Therapy for Relapsed/Refractory Multiple Myeloma (MM) Patients Progressing after Bcma-Directed CAR T Cells 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Predictors of T Cell Expansion and Clinical Responses Following B-Cell Maturation Antigen-Specific Chimeric Antigen Receptor T Cell Therapy (CART-BCMA) for Relapsed/Re... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• CAR-T and Cellular Therapy in Myeloma 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/1/2018
• Join now to see all